(ETON) –
-
Form S-8 Eton Pharmaceuticals,
-
Form 10-K/A Eton Pharmaceuticals, For: Dec 31
-
Form 8-K Eton Pharmaceuticals, For: Mar 22
-
Eton Pharmaceuticals (ETON) Acquires PKU GOLIKE for Phenylketonuria
-
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
-
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKEĀ® for Phenylketonuria
-
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKEĀ® for Phenylketonuria
-
Form 10-K Eton Pharmaceuticals, For: Dec 31
-
Eton Pharmaceuticals Inc. (ETON) Misses Q4 EPS by 5c
-
Form 8-K Eton Pharmaceuticals, For: Mar 14
-
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
-
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
-
Eton Pharmaceuticals Inc. (ETON) awarded U.S. patent for proprietary formulation of oral liquid hydrocortisone
-
Form 8-K Eton Pharmaceuticals, For: Feb 21
-
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
-
Form 4 Eton Pharmaceuticals, For: Feb 13 Filed by: Gruber James R.
-
Form 4 Eton Pharmaceuticals, For: Feb 13 Filed by: Adams Jennifer McKie
-
Form 4 Eton Pharmaceuticals, For: Feb 13 Filed by: BRYNJELSEN SEAN
-
Form 4 Eton Pharmaceuticals, For: Feb 13 Filed by: CASAMENTO CHARLES J
-
Form 4 Eton Pharmaceuticals, For: Feb 13 Filed by: Krempa David
-
Form 4 Eton Pharmaceuticals, For: Feb 13 Filed by: MAIER PAUL V
-
Form 4 Eton Pharmaceuticals, For: Feb 13 Filed by: RIEDEL NORBERT G
-
Form SC 13G/A Eton Pharmaceuticals, Filed by: Opaleye Management Inc.
-
Form 8-K Eton Pharmaceuticals, For: Feb 02
-
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
-
Eton Pharmaceuticals Inc. (ETON) Tops Q3 EPS by 8c
-
Form 10-Q Eton Pharmaceuticals, For: Sep 30
-
Form 8-K Eton Pharmaceuticals, For: Nov 09
-
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
-
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
-
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
-
Form 8-K Eton Pharmaceuticals, For: Oct 04
-
Eton Pharmaceuticals (ETON) Acquires FDA-Approved Ultra-Rare Disease Product Nitisinone
-
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
-
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
-
Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 27c, beats revenue
-
Form 10-Q Eton Pharmaceuticals, For: Jun 30
-
Form 8-K Eton Pharmaceuticals, For: Aug 10
-
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
-
Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
-
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
-
Form 8-K Eton Pharmaceuticals, For: Jun 30
-
Eton Pharmaceuticals (ETON) PT Lowered to $9 at H.C. Wainwright
-
Form 8-K Eton Pharmaceuticals, For: Jun 28
-
Eton Pharmaceuticals (ETON) Receives FDA CRL for Dehydrated Alcohol Injection
-
Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
-
Form 8-K Eton Pharmaceuticals, For: Jun 09
-
Form 8-K Eton Pharmaceuticals, For: Jun 13
-
Form 10-Q Eton Pharmaceuticals, For: Mar 31
-
Form 8-K Eton Pharmaceuticals, For: May 11
Back to ETON Stock Lookup